ST. JOHNS GROUP PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: C86020 | DONCASTER, DN4 0TH
Showing results 151-200 of 600
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 233 | 1,810 | £495 | +11.5% ▲ | |
| Betahistine hydrochloride | 232 | 19.0K | £855 | -2.8% ▼ |
| Clobetasone butyrate | 231 | 12.4K | £2.0K | +13.2% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 229 | 26.2K | £1.7K | +1.3% vs avg |
| Mesalazine (Systemic) | 227 | 21.2K | £10.0K | -5.2% ▼ |
| Biphasic insulin aspart | 226 | 1,571 | £9.3K | +122.6% ▲ |
| Pravastatin sodium | 224 | 6,272 | £281 | -31.0% ▼ |
| Dorzolamide | 218 | 5,385 | £2.4K | +162.3% ▲ |
| Carbomer 940/980 | 217 | 3,120 | £625 | +42.5% ▲ |
| Oxycodone hydrochloride | 216 | 24.9K | £3.1K | -15.6% ▼ |
| Fluticasone furoate/vilanterol | 212 | 212 | £4.9K | +36.9% ▲ |
| Canagliflozin | 211 | 6,344 | £7.9K | +47.0% ▲ |
| Bumetanide | 208 | 10.4K | £979 | -23.7% ▼ |
| Irbesartan | 206 | 6,244 | £272 | -15.5% ▼ |
| Baclofen | 202 | 62.1K | £742 | +0.8% vs avg |
| 201 | 1,961 | £1.2K | +96.8% ▲ | |
| Sodium valproate | 200 | 21.1K | £4.2K | -37.1% ▼ |
| Fluticasone propionate (Inhalation) | 199 | 199 | £4.9K | -48.6% ▼ |
| Tiotropium bromide | 198 | 198 | £4.3K | -34.9% ▼ |
| Orlistat | 197 | 17.0K | £4.1K | +139.0% ▲ |
| Clobetasol propionate | 193 | 13.5K | £1.0K | +41.5% ▲ |
| Nifedipine | 191 | 13.2K | £2.9K | +1.9% vs avg |
| Tadalafil | 191 | 3,090 | £574 | +12.3% ▲ |
| Letrozole | 191 | 5,348 | £496 | +2.3% ▲ |
| Clotrimazole | 187 | 875 | £1.6K | +69.5% ▲ |
| Aciclovir | 185 | 9,047 | £395 | +24.4% ▲ |
| Sacubitril/valsartan | 182 | 10.1K | £16.5K | -24.0% ▼ |
| Medroxyprogesterone acetate | 182 | 182 | £1.0K | +50.7% ▲ |
| Carbimazole | 179 | 7,328 | £683 | +58.5% ▲ |
| Umeclidinium bromide | 176 | 176 | £4.6K | +185.5% ▲ |
| Promethazine hydrochloride | 175 | 6,146 | £836 | -51.0% ▼ |
| Insulin detemir | 175 | 1,071 | £9.0K | +123.4% ▲ |
| 175 | 175 | £844 | +329.9% ▲ | |
| Pramipexole | 174 | 10.5K | £1.0K | +77.2% ▲ |
| Quinine sulfate | 174 | 4,940 | £1.0K | -39.9% ▼ |
| Prochlorperazine maleate | 173 | 7,163 | £429 | -14.4% ▼ |
| Sulfasalazine | 171 | 20.4K | £1.9K | +31.4% ▲ |
| Memantine hydrochloride | 170 | 4,768 | £813 | -48.5% ▼ |
| Fesoterodine fumarate | 168 | 5,376 | £450 | +325.9% ▲ |
| Paroxetine hydrochloride | 166 | 5,416 | £196 | -11.0% ▼ |
| Bisacodyl | 165 | 10.6K | £554 | +25.9% ▲ |
| Peppermint oil | 162 | 14.9K | £1.3K | +103.6% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 159 | 20.4K | £921 | -11.5% ▼ |
| Fentanyl | 158 | 1,698 | £7.5K | +54.2% ▲ |
| Lymecycline | 155 | 4,648 | £534 | +28.9% ▲ |
| 155 | 15.8K | £982 | +122.1% ▲ | |
| Clonazepam | 154 | 7,046 | £1.0K | -1.2% vs avg |
| Colchicine | 153 | 8,246 | £160 | +96.2% ▲ |
| Diltiazem hydrochloride | 152 | 6,076 | £1.2K | -50.5% ▼ |
| Risedronate sodium | 151 | 604 | £161 | +24.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.